In 90–95% of patients diagnosed with classic RTT, the disease is caused by loss-of-function mutations in the X- linked MECP2 gene, which encodes methyl-CpG binding protein 2 (MECP2) [1, 2]. The gene discussed is MECP2; the disease is Rett syndrome.